6-Nov-2025 8:30 AM CST - Business Wire Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and webcast on Friday, November 14, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 230582 Webcast Link https://www.webcaster5.com/Webcast/Page/2865/53145 About Tivic Health Systems, Inc. T
14-Aug-2025 3:00 PM CST - Business Wire Tivic Reports Second Quarter 2025 Financial Results Tivic Health Systems, Inc. (NASDAQ: TIVC), a diversified immunotherapeutics company, today announced financial results for the second quarter and six months ended June 30, 2025. We have established a strong foundation for Tivics strategic transformation with our expansion into biopharmaceuticals, making us unique in treating disease by addressing both the bodys biochemical and bioelectronic systems, stated Tivic CEO Jennifer Ernst. To maximize our focus o
7-Aug-2025 7:30 AM CST - Business Wire Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced that it will report its second quarter results for 2025 via pre-recorded conference call and webcast on Thursday, August 14, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 877-545-0523 International: 973-528-0016 Participant Access Code: 793820 Webcast Link https://www.we
24-Jun-2025 7:30 AM CST - Business Wire Tivic Health Announces 2025 Annual Meeting of Stockholders Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time | 4:00 PM Eastern Time. The Company has adopted a virtual format for its Annual Meeting to provide a consistent and convenient experience for all stockholders regardless of their location. In lieu of a live Q&A session, stockholders can submit questio
15-May-2025 3:05 PM CST - Business Wire Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced financial results for the first quarter ended March 31, 2025 and outlined operational highlights based on its newly expanded clinical pipeline. This is a defining time for the company. During the quarter we initiated a significant strategic shift, dramatically expanding Tivic's clinical pipeline for restoring immune system health," stated Tivic CEO Jennifer Er
9-May-2025 7:30 AM CST - Business Wire Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its first quarter results for 2025 via pre-recorded conference call and webcast on Thursday, May 15, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID: 13753498 Webcast Li
21-Mar-2025 3:00 PM CST - Business Wire Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced year end December 31, 2024 financial results, highlighted key developments in its clinical program expansion and discussed progress made across the companys operations. The important strategic events of the past several months have been nothing short of transformative, stated Tivic Health Chief Executive Officer, Jennifer Ernst. We have successfully reshaped the
13-Mar-2025 3:59 PM CST - Business Wire Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast Tivic Health Systems, Inc. (Tivic Health, Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its year-end financial results for 2024 via pre-recorded conference call and webcast on Friday, March 21, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID
14-Nov-2024 10:36 PM CST - Business Wire Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024 financial results and discussed growth strategies based on its novel, patent-pending vagus nerve stimulation (VNS) science and device technology. This quarter we made significant progress on each of the three prongs of our strategy for delivering shareholder value," st
6-Nov-2025 8:30 AM CST - Business Wire Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and webcast on Friday, November 14, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 888-506-0062 International: 973-528-0011 Participant Access Code: 230582 Webcast Link https://www.webcaster5.com/Webcast/Page/2865/53145 About Tivic Health Systems, Inc. T
14-Aug-2025 3:00 PM CST - Business Wire Tivic Reports Second Quarter 2025 Financial Results Tivic Health Systems, Inc. (NASDAQ: TIVC), a diversified immunotherapeutics company, today announced financial results for the second quarter and six months ended June 30, 2025. We have established a strong foundation for Tivics strategic transformation with our expansion into biopharmaceuticals, making us unique in treating disease by addressing both the bodys biochemical and bioelectronic systems, stated Tivic CEO Jennifer Ernst. To maximize our focus o
7-Aug-2025 7:30 AM CST - Business Wire Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced that it will report its second quarter results for 2025 via pre-recorded conference call and webcast on Thursday, August 14, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 877-545-0523 International: 973-528-0016 Participant Access Code: 793820 Webcast Link https://www.we
24-Jun-2025 7:30 AM CST - Business Wire Tivic Health Announces 2025 Annual Meeting of Stockholders Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today its Virtual Annual General Meeting of Shareholders will be held on Monday, June 30, 2025 at 1:00 PM, Pacific Time | 4:00 PM Eastern Time. The Company has adopted a virtual format for its Annual Meeting to provide a consistent and convenient experience for all stockholders regardless of their location. In lieu of a live Q&A session, stockholders can submit questio
15-May-2025 3:05 PM CST - Business Wire Tivic Reports First Quarter 2025 Financial Results and Provides Updates on Business Transformation Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced financial results for the first quarter ended March 31, 2025 and outlined operational highlights based on its newly expanded clinical pipeline. This is a defining time for the company. During the quarter we initiated a significant strategic shift, dramatically expanding Tivic's clinical pipeline for restoring immune system health," stated Tivic CEO Jennifer Er
9-May-2025 7:30 AM CST - Business Wire Tivic Health to Report First Quarter 2025 Financial Results on May 15th Via Conference Call and Webcast Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its first quarter results for 2025 via pre-recorded conference call and webcast on Thursday, May 15, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID: 13753498 Webcast Li
21-Mar-2025 3:00 PM CST - Business Wire Tivic Reports Year End 2024 Financial Results and Provides Overview of Strategy for Transformation and Growth Tivic Health Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, today announced year end December 31, 2024 financial results, highlighted key developments in its clinical program expansion and discussed progress made across the companys operations. The important strategic events of the past several months have been nothing short of transformative, stated Tivic Health Chief Executive Officer, Jennifer Ernst. We have successfully reshaped the
13-Mar-2025 3:59 PM CST - Business Wire Tivic Health to Report 2024 Year-End Financial Results on March 21st Via Conference Call and Webcast Tivic Health Systems, Inc. (Tivic Health, Nasdaq: TIVC), a diversified therapeutics company harnessing the power of the immune and autonomic nervous systems to fight disease and restore health, today announced that it will report its year-end financial results for 2024 via pre-recorded conference call and webcast on Friday, March 21, 2025 at 1:30 PM PT / 4:30 PM ET. Teleconference Details: Toll Free: 1-877-407-0779 International: 1-201-389-0914 Conference ID
14-Nov-2024 10:36 PM CST - Business Wire Tivic Reports Third Quarter 2024 Financial Results and Provides Business Update Tivic Health Systems, Inc. (Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced third quarter and nine-months ended September, 30, 2024 financial results and discussed growth strategies based on its novel, patent-pending vagus nerve stimulation (VNS) science and device technology. This quarter we made significant progress on each of the three prongs of our strategy for delivering shareholder value," st
